Bronchopulmonary dysplasia (BPD) is a major complication in prematurely born infants.
Pulmonary hypertension (PH) associated with BPD (BPD-PH) is characterized by alveolar …

Bronchopulmonary dysplasia (BPD) is the leading cause of chronic lung disease in infants
and the commonest complication of prematurity. Advances in respiratory and overall …

Rationale: Bronchopulmonary dysplasia (BPD) is a heterogenous condition with poorly
characterized disease subgroups. Objectives: To define the frequency of three disease …

Bronchopulmonary dysplasia is the most frequent adverse outcome of prematurity. Before
implementation of antenatal steroids and surfactant therapy, bronchopulmonary dysplasia …

Bronchopulmonary dysplasia (BPD) is a common long-term complication of preterm birth.
The chest radiograph appearance and survivability have evolved since the first description …

Bronchopulmonary dysplasia (BPD) remains the most common complication of premature
birth, imposing a significant and potentially life-long burden on patients and their families …

Approximately 8–42% of premature infants with chronic lung disease of prematurity,
bronchopulmonary dysplasia (BPD), develop pulmonary hypertension (PH). Infants with …

Pediatric pulmonary hypertension (PPH) is a multifactorial disease with diverse etiologies
and presenting features. Pulmonary hypertension (PH), defined as elevated pulmonary …

Background Pulmonary vascular disease (PVD) affects the majority of preterm neonates with
bronchopulmonary dysplasia (BPD) and significantly determines long-term mortality through …

Bronchopulmonary dysplasia (BPD) is a complex and serious cardiopulmonary morbidity in
infants who are born preterm. Despite advances in clinical care, BPD remains a significant …